Replies to post #24106 on RespireRx Pharmaceuticals Inc (fka RSPI)

[jerrydylan]

I guess I am aggravated that we sit here unpartnered and the only partner we really have just got aquired-

[DewDiligence]

Actually, SGP has two of the best phase-3 assets in the entire drug/biotech industry: TRA, an antiplatelet drug for various cardiovascular indications; and Boceprevir, a protease inhibitor for HCV.